Health Tech Capitol | Lucigen to License Epicentre Products
16083
post-template-default,single,single-post,postid-16083,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Lucigen to License Epicentre Products

Lucigen to License Epicentre Products

Lucigen is licensing Epicentre’s entire product portfolio from Illumina, the company announced recently.

According to a release, Lucigen now has exclusive rights to manufacture and sell Epicentre products through its worldwide distribution network. Illumina acquired Madison-based Epicentre in 2011.

“We are excited to be able to offer this complete line of genomics products to researchers,” Lucigen President Jeff Williams said in a statement. “A combined Lucigen and Epicentre product portfolio provides a broad set of unique tools that deliver innovation and ease of use to life scientists.”

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.